142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

315354
ASTHO's Capacity Building Assistance and Results from a 50 State Inventory

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 8:50 AM - 9:10 AM

Paul E. Jarris, MD , ASTHO, The Association of State and Territorial Health Officials, Arlington, VA
ASTHO has partnered with strategic partners to engage with states to develop a leadership community to support a comprehensive approach to Prescription Drug Misuse and Abuse by focusing on prevention, treatment and recovery, enforcement, and surveillance. ASTHO completed a 50 state inventory of state policies in each of the categories and will present high level results of the data. Lessons Learned: Recommendations: (1) Engage health care professionals, consumers, families and communities in effective prevention strategies; (2) use monitoring and surveillance to improve public health and clinical practice; (3) improve collaboration between public health and law enforcement; (4) approach addiction as a treatable chronic illness.

Learning Areas:

Public health administration or related administration
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
Discuss how the state public health is improving state responses to prescription drug abuse misuse and abuse.

Keyword(s): Drug Abuse Prevention and Safety, Public Health Policy

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Paul E. Jarris, MD, MBA is Executive Director of ASTHO. Dr. Jarris served as Vermontís state health official from 2003 to 2006. His past leadership positions include Medical Director for Vermontís largest nonprofit HMO, President of Vermont Permanente Medical Group and CEO of Primary Care Health Partners. He is certified by the American Board of Family Medicine and the American Board of Medical Management and is member of the IOM Board on Health Sciences Policy.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.